510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K860046Substantially Equivalent

Determination of Phenobarbital

Clinical Data, Inc., Boston MA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K860046 is the FDA 510(k) clearance record for DETERMINATION OF PHENOBARBITAL, a class II device, cleared for Clinical Data, Inc. on under FDA product code DLZ (Enzyme Immunoassay, Phenobarbital). FDA records list 37 510(k) clearances for Clinical Data, Inc., from to . As of , FDA records show no recalls naming K860046.

Clearance record

Decision date
Received
(16 days to decision)
Product code
DLZ Enzyme Immunoassay, Phenobarbital
Regulation
21 CFR 862.3660
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Clinical Data, Inc. 1172 Commonwealth Ave., Boston MA
Third party review
No

Clearances, product code DLZ

Trailing 12 months

FDA records hold no clearances under product code DLZ in the trailing twelve months.

FDA records show no clearances under product code DLZ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DLZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260